Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: A prospective randomized pilot study

Journal of Neurosurgical Anesthesiology

Volumn 18, Issue 2, 2006, Pages 142-148

  Wong, George K C ^a   Chan, Matthew T V ^a   Boet, Ronald ^a   Poon, Wai S ^a   Gin, Tony ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Intracranial aneurysm; Magnesium sulfate; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

HYPERTENSIVE AGENT; MAGNESIUM SULFATE; NIMODIPINE; SODIUM CHLORIDE; NEUROPROTECTIVE AGENT;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BLOOD FLOW VELOCITY; BRAIN ARTERY ANEURYSM; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN VASOSPASM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG EFFECT; FEMALE; GLASGOW OUTCOME SCALE; HEART DISEASE; HOSPITAL INFECTION; HUMAN; HYDROCEPHALUS; HYPERVOLEMIA; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NEUROPROTECTION; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SUBARACHNOID HEMORRHAGE; ACUTE DISEASE; ECHOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; NEUROSURGERY; RISK FACTOR; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM SULFATE; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; NEUROSURGICAL PROCEDURES; PROSPECTIVE STUDIES; RISK FACTORS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASOSPASM, INTRACRANIAL;

EID: 33646848055     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-200604000-00009     Document Type: Article

References (29)

1. Ross N, Hutchinson PJ, Seeley H, et al. Timing of surgery for supratentorial aneurysmal subarachnoid haemorrhage: report of a prospective study. J Neurol Neurosurg Psychiatry. 2002;72:480-484.
2. Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267-1274.
3. Goddard AJ, Raju PP, Gholkar A. Does the method of treatment of acutely ruptured intracranial aneurysms influence the incidence and duration of cerebral vasospasm and clinical outcome? J Neurol Neurosurg Psychiatry. 2004;75:868-872.
4. Perales AJ, Torregrosa G, Salom JB, et al. In vivo and in vitro effects of magnesium sulfate in the cerebrovascular bed of the goat. Am J Obstet Gynecol. 1991;165:1534-1538.
5. 2+ in isolated human cerebral arteries. Eur J Pharmacol. 1992;229:83-89.
6. Ram Z, Sadeh M, Shacked I, et al. Magnesium sulfate reverses experimental delayed vasospasm after subarachnoid hemorrhage in rats. Stroke. 1991;22:922-927.
7. Nowak L, Bregestovski P, Ascher P, et al. Magnesium gates glutamate-activated channels in mouse central neurons. Nature. 1984;307:462-465.
8. Lin JY, Chung SY, Lin MC, et al. Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique. Life Sci. 2002;71:803-811.
9. Altman D, Carroli G, Duley L, et al. Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877-1890.
10. Belfort MA, Anthony J, Saade GR, et al. Nimodipine Study Group. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med. 2003;348:304-311.
11. Drake CG. Report of World Federation of Neurological Surgeons committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988;68:985-986.
12. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1-9.
13. Lindegaard KF, Nornes H, Bakke SJ, et al. Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien). 1989;100:12-24.
14. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480-484.
15. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61-65.
16. Lyden PD, Lu M, Levine SR, et al. NINDS rtPA Stroke Study Group. A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity. Stroke. 2001;32:1310-1317.
17. Macdonald RL, Curry DJ, Aihara Y, et al. Magnesium and experimental vasospasm. J Neurosurg. 2004;100:106-110.
18. Izumi Y, Roussel S, Pinard E, et al. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab. 1991;11:1025-1030.
19. Marinov MB, Harbaugh KS, Hoopes PJ, et al. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg. 1996;85:117-124.
20. Yang Y, Li Q, Ahmad F, et al. Survival and histological evaluation of therapeutic window of post-ischemia treatment with magnesium sulfate in embolic stroke model of rat. Neurosci Lett. 2000;285:119-122.
21. Muir KW, Lees KR, Ford I, et al. Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet. 2004;363:439-445.
22. Saver JL, Kidwell C, Eckstein M, et al. FAST-MAG Pilot Trial Investigators. Prehospital neuroprotective therapy for acute stroke. Results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke. 2004;35:e106-e108.
23. Veyna RS, Seyfried D, Burke DG, et al. Magnesium sulfate therapy after aneurysmal subarachnoid haemorrhage. J Neurosurg. 2002;96:510-514.
24. van den Bergh WM, Algra A, van Kooten F, et al. MASH Study Group. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005;36:1011-1015.
25. van den Bergh WM, Algra A, van der Sprenkel JW, et al. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2003;52:276-281.
26. Collignon FP, Friedman JA, Piepgras DG, et al. Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2004;1:441-448.
27. Sviri GE, Lewis DH, Correa R, et al. Basilar artery vasospasm and delayed posterior circulation ischemia after aneurysmal subarachnoid hemorrhage. Stroke. 2004;35:1867-1872.
28. Boet R, Mee E. Magnesium sulfate in the management of patients with fisher grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery. 2000;47:602-607.
29. Noronha JL, Matuschak GM. Magnesium in critical illness: metabolism, assessment, and treatment. Intensive Care Med. 2002;28:667-679.